Philippe Le Goff joined Spencer Stuart’s Zurich office in 2000. He leads the firm’s global Life Sciences Practice and is a member of the firm’s Board Services Practice. He has 25 years of prior corporate experience in the healthcare sector. Phil has held senior positions in general management, sales and marketing, and research and development within the pharmaceutical and medical device arenas.
Prior to joining Spencer Stuart, Phil served as group president of vascular and non-vascular businesses at Boston Scientific Corporation in the U.S.A. Prior to that, he was head of strategy, business development, and public affairs and a member of the global executive committee at Novartis Pharma in Basel, Switzerland. Phil had previously spent 13 years with Sanofi, where he served in several senior positions, including CEO of Sanofi North America in New York, and worldwide president of the bio-industries division in Paris. He began his career with Ciba-Geigy, where he held positions of increasing responsibility in Switzerland, Brazil and the U.K.
Phil holds degrees in pharmacy and organic chemistry from the University of Rennes, France, an M.B.A. from Stanford University, and a Ph.D. in health care law from the University of Paris. He has served on the boards of several international organizations, including the Council of the International Federation of Pharmaceuticals Manufacturers' Associations (IFPMA, Geneva), InterPharma (Basel) and the Policy Board of The Centre for Medicines Research (CMR, London).